Biden’s vaccine change has risky side effects

Joe Biden’s vaccine revolution risks creating lingering ailments. The US president’s decision to support the removal of intellectual property protections on Covid-19 jabs is a logical move, but practical difficulties mean that he may not do much to help countries ravaged by the pandemic. The danger is that Big Pharma …

Read More »

Letters to the Editor of May 10, 2021

The world now has vaccines in its arsenal to keep the Covid-19 pandemic under control, but the grim reality facing it is vaccine inequity. While the rich and developed world has accumulated vaccines, the poor countries have for the most part been left to fend for themselves. Their persistent struggle …

Read More »

NOXXON Pharma N Announces Data Safety Monitoring Board Validates Highest Dose of NOX-A12 in Phase 1/2 Brain Cancer Trial

NOXXON ANNOUNCES DATA SECURITY SUPERVISORY BOARD VALIDATES THE HIGHEST DOSE OF NOX-A12 IN THE PHASE 1/2 BRAIN CANCER TRIAL Berlin, Germany, May 10, 2021, 6:00 p.m. CEST – NOXXON Pharma NV (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting the tumor microenvironment (TME), today …

Read More »

Amgen asks FDA to approve key asthma drug

Dive brief: Amgen said on Monday that it had submitted its asthma drug tezepelumab for approval to the Food and Drug Administration, promising a drug that is critically important to its plans to grow beyond Aging blockbusters that have supported his business for years. Tezepelumab, which Amgen has been developing …

Read More »